Literature DB >> 22964486

Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease.

Candan Depboylu1, Sarah Stricker, Jean-Pierre Ghobril, Wolfgang H Oertel, Josef Priller, Günter U Höglinger.   

Abstract

Parkinson disease (PD) is characterized by dopaminergic neurodegeneration in the substantia nigra (SN). Recent evidence suggests that innate and adaptive immune responses can influence dopaminergic cell death in animal models of PD. However, the precise role of mononuclear phagocytes, key players in damaged tissue clearance and cross-talk with cells of adaptive immune system, remains open in PD. Mononuclear phagocytes in the brain occur as brain-resident microglia and as brain-infiltrating myeloid cells. To elucidate their differential contribution in the uptake of dopaminergic cell debris and antigen presentation capacity, we labeled nigral dopaminergic neurons retrogradely with inert rhodamine-conjugated latex retrobeads before inducing their degeneration by subchronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration. We used green fluorescent protein (GFP)-expressing bone marrow chimeric mice to differentiate brain-infiltrating from brain-resident myeloid cells. We found that half of both endogenous (GFP-) and exogenous (GFP+) microglia (Iba1+) in the SN incorporated the tracer from degenerating dopaminergic neurons 1d after MPTP intoxication. In absolute numbers, endogenous microglia were much more activated to macrophages compared to exogenous myeloid cells at 1d after MPTP. Mainly the endogenous, tracer-phagocytosing microglia expressed the major histocompatibility complex (MHC) class II molecule for antigen presentation. Additionally, T-lymphocytes (Iba1-/GFP+/CD3+), which infiltrate the MPTP-lesioned SN, were mainly in direct contact with MHCII+ endogenous microglia. Our data suggest that brain-resident microglia are predominantly implicated in the removal of dopaminergic cell debris and the cross-talk with infiltrating T-lymphocytes in the SN in the MPTP mouse model of PD.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964486     DOI: 10.1016/j.expneurol.2012.08.020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  43 in total

1.  Astragalus polysaccharide attenuates lipopolysaccharide-induced inflammatory responses in microglial cells: regulation of protein kinase B and nuclear factor-κB signaling.

Authors:  Tao Luo; Jian Qin; Min Liu; Jun Luo; Fang Ding; Mingling Wang; Limin Zheng
Journal:  Inflamm Res       Date:  2015-02-11       Impact factor: 4.575

2.  Inflaming the diseased brain: a role for tainted melanins.

Authors:  T M Jeitner; M Kalogiannis; P A Patrick; I Gomolin; T Palaia; L Ragolia; D Brand; E J Delikatny
Journal:  Biochim Biophys Acta       Date:  2015-01-10

3.  Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.

Authors:  Jinbo Cheng; Yajin Liao; Yuan Dong; Han Hu; Nannan Yang; Xiangxi Kong; Shuoshuo Li; Xiaoheng Li; Jifeng Guo; Lixia Qin; Jiezhong Yu; Cungen Ma; Jianke Li; Mingtao Li; Beisha Tang; Zengqiang Yuan
Journal:  Autophagy       Date:  2020-01-31       Impact factor: 16.016

Review 4.  Let's make microglia great again in neurodegenerative disorders.

Authors:  Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

5.  Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease models.

Authors:  Daniela Lecca; Elzbieta Janda; Giovanna Mulas; Andrea Diana; Concetta Martino; Fabrizio Angius; Stefano Spolitu; Maria Antonietta Casu; Gabriella Simbula; Laura Boi; Barbara Batetta; Saturnino Spiga; Anna R Carta
Journal:  Br J Pharmacol       Date:  2018-07-12       Impact factor: 8.739

Review 6.  Differential contribution of microglia and monocytes in neurodegenerative diseases.

Authors:  Caroline Baufeld; Elaine O'Loughlin; Narghes Calcagno; Charlotte Madore; Oleg Butovsky
Journal:  J Neural Transm (Vienna)       Date:  2017-10-23       Impact factor: 3.575

7.  Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease.

Authors:  Qiu-Shuang Zhang; Yang Heng; Zheng Mou; Ju-Yang Huang; Yu-He Yuan; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2017-06-26       Impact factor: 6.150

8.  Lovastatin induces neuroprotection by inhibiting inflammatory cytokines in 6-hydroxydopamine treated microglia cells.

Authors:  Jun-Qiang Yan; Jia-Chun Sun; Ming-Ming Zhai; Li-Niu Cheng; Xiao-Li Bai; Cui-Ling Feng
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 9.  Astroglia in Alzheimer's Disease.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Jose Julio Rodriguez-Arellano; Robert Zorec
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Association analysis of HLA-DRA in Chinese patients with sporadic Parkinson's disease.

Authors:  Ming-Shu Mo; You-Sheng Xiao; Zhuo-Hua Wu; Cong-Cong Sun; Li-Min Zhang; Luan Cen; Xiang Chen; Shao-Gang Qu; Xin-Ling Yang; Ping-Yi Xu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.